Multi-Systems: Antiviral Agents Flashcards
(2) Anti-herpes-viral drugs that are Guanosine analogs that
inhibit Nucleic Acid Synthesis?
Acyclovir (HSV, VZV)
Ganciclovir (CMV)
Mechanism of Acyclovir and Ganciclovir?
- Acts as a Chain terminator and Viral DNA Polymerase Inhibitor (HSV-enzyme required to activate)
- Guanosine analog w/ Acyclic Sugar
- Phosphorylated by Viral Thymidine Kinase
- -> acylcoGMP –> acycloGTP
- Valacyclovir + H2O –> Acyclovir + Valine
- Valganciclovir + H2O –> Ganciclovir + Valine
Clinical use of Acyclovir and Ganciclovir?
-
Acyclovir
- HSV-1, HSV-2
- VZV
- EBV
-
Ganciclovir
- CMV
- HHV-6, HHV-7
Resistance to Acyclovir and Ganciclover?
- Deleted or Mutated - Viral Tyrosine Kinase
- Resistant - Viral DNA Polymerase
- No effect during latent infection because Viral Tyrosine Kinase is not expressed
Drugs that work on CMV?
- Ganciclovir (Guanosine analog)
- Foscarnet (Viral DNA polymerase inhibitor)
(2) Anti-herpes-viral, Viral DNA polymerase inhibitors that stop Nucleid Acid Synthesis?
- Foscarnet (CMV)
- Cidofovir (HSV* - Acyclovir resistant)
Mechanism of Foscarnet?
- An inorganic pyrophospate analog that Inhibits Viral DNA polymerase w/out requireng activation via Phosphorylation by Viral Kinases.
- Effective against resistant strains of HSV, VSV, and CMV
Clinical use of Foscarnet?
- Acyclovir-resistant HSV and VZV
-
Ganciclovir-resistant CMV
- Produces less Bone Marrow suppression than Ganciclovir
SEs of Foscarnet?
- Nephrotoxicity
- Foscarnet acts as a Potent Chelator of divalent Cations
- -> decreased ionized Ca2+, Mg2+
- -> Symptomatic Hypocalcemia w/ normal Serum Ca2+
Resistance to Foscarnet?
- Foscarnet binds to the pyrophosphate binding site of the DNA polymerase
- -> Mutations in DNA Polymerase that prevent binding
(2) Antiviral drugs that Block the
Influenza A M2 Protein Channel
–> Preventing Uncoating of Influenza virion
–> Req’d for Infection
- Amantadine
- Rimantadine
Mechanism of Amantadine and Rimantadine?
- M2 channel conducts Protons from the Endosome into the Virion
- -> Acidification of the Interior and Dissociation of the Matrix protein from Viral ribonucleoproteins (RNPs)
- Amantadine / Rimantadine prevent Virion from fusing w/ the Endosomal membrane and stops from Releasing contents into Cytoplasm
Clinical use of Amantadine and Rimantadine?
- Influenza A infections
- No longer used though due to increased Resistance
- Resistance arises rapidly via Single-point mutation of M2 protein
(1) Hepatitis Anti-viral, Guanine nucleotide Synthesis that Inhibits Nucleic Acid Synthesis?
- Ribavirin
Mechanism of Ribavirin?
- Guanosine analog that is Phosphorylated by Cellular enzymes
- Inhibits Syn. of Guanine Nucleotides by competitively inhibiting Inosine Monophosphate Dehydrogenase
- Inhibits IMP dehydrogenase
- -> Impaired Purine synthesis
- Inhibits Viral RNA polymerase and 5’ cap formation on mRNAs
Clinical use of Ribavirin?
- Chronic HCV Infection (in combination w/ IFN-α)
SEs of Ribavirin?
- Hemolytic anemia when administered IV
- Severe Teratogenic
- Oncogenic
- Gonadotoxic
Small polypeptide (18 kd) that binds to a cellular receptor
and Induces a Antiviral Cellular State?
- IFN-α
Mechanism of IFN-α?
-
Binds to Cellular Receptor and Induces a Antiviral Cellular State
- Phosph. of EF 2 –> Inhibit Peptide Chain Initiation
- Ribonuclease Activation –> degrade Viral mRNA
- Phosphodiesterase exp –> degrade tRNAs
- -> inhibit Peptide Chain Elongation
- Increase Natural killer cell lytic function
- Increase exp. of MHC Class I molecules
Clinical use of IFN-α?
- Chronic Hepatitis B and Hepatitis C Infections
-
Anti-tumor effect on various cancers
- Melanoma
- Hairy cell leukemia
- Kaposi’s Sarcoma
SEs of IFN-α?
-
Flu-like Symptoms
- Fever
- Myalgias
- Malaise
- Neutropenia
- Thrombocytopenia
(2) Drugs that Reversibly Inhibit Neuraminidase (NA)
of Influenza A and B and impairs budding of Virions?
- Zanamivir
- Oseltamivir